Clinical Trial

A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors

Name: A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors — clinical trial record (NCT07093970)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The objective of this study is to assess the safety, efficacy, pharmacokinetics, and immunogenicity of MRG006A in patients with advanced solid tumors.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-07-29.

Trial Details

NCT Number	NCT07093970
Lead Sponsor	Lepu Biopharma Co., Ltd.
Conditions	Advanced Solid Tumors
Enrollment	343 participants
Start Date	2024-07-24
Primary Completion	2027-12 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-01-22